PPARA and breast carcinoma: It is likely that the breast epithelium of diabetics exposed toTZDs will also experience perturbation of the PPAR signaling pathway.Consequently, current or past TZD users’ lifetime breast carcinoma risks may bemodified, as their breast lesion incidence or rates of the conversion of these lesionsto carcinomas might change upward or downward.